Band 4.2 Shiga: 317 CGC-->TGC in compound heterozygotes with 142 GCT-->ACT results in band 4.2 deficiency and microspherocytosis.

MLA

Kanzaki, A., et al. “Band 4.2 Shiga: 317 CGC-->TGC in Compound Heterozygotes with 142 GCT-->ACT Results in Band 4.2 Deficiency and Microspherocytosis.” British Journal of Haematology, vol. 91, no. 2, Oct. 1995, pp. 333–40. EBSCOhost, https://doi.org/10.1111/j.1365-2141.1995.tb05299.x.

APA

Kanzaki, A., Yasunaga, M., Okamoto, N., Inoue, T., Yawata, A., Wada, H., Andoh, A., Hodohara, K., Fujiyama, Y., Bamba, T., & et. al. (1995). Band 4.2 Shiga: 317 CGC-->TGC in compound heterozygotes with 142 GCT-->ACT results in band 4.2 deficiency and microspherocytosis. British Journal of Haematology, 91(2), 333–340. https://doi.org/10.1111/j.1365-2141.1995.tb05299.x

Chicago

Kanzaki, A, M Yasunaga, N Okamoto, T Inoue, A Yawata, H Wada, A Andoh, et al. 1995. “Band 4.2 Shiga: 317 CGC-->TGC in Compound Heterozygotes with 142 GCT-->ACT Results in Band 4.2 Deficiency and Microspherocytosis.” British Journal of Haematology 91 (2): 333–40. doi:10.1111/j.1365-2141.1995.tb05299.x.